Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity.
Pourhassan H, La Rosa C, Chiuppesi F, Puing A, Aldoss I, Park Y, Zhou Q, Karpinski V, Faircloth K, Kaltcheva T, Johnson D, Francisco SO, Zaia JA, Nakamura R, Al Malki MM, Diamond DJ, Dadwal SS, Forman SJ.
Pourhassan H, et al. Among authors: nakamura r.
Blood Adv. 2022 Mar 22;6(6):1645-1650. doi: 10.1182/bloodadvances.2021006282.
Blood Adv. 2022.
PMID: 35008104
Free PMC article.